Adrian V. S. Hill
Gründer bei Oxxon Therapeutics, Inc.
Profil
Adrian V.
S.
Hill is the founder of RioTech Pharmaceuticals Ltd.
founded in 2001.
He is currently a Principal at the University of Oxford.
Mr. Hill's education history includes an undergraduate degree from Magdalen College School Oxford Ltd in 1982.
Mr. Hill is also the founder of Oxxon Therapeutics, Inc.
Aktive Positionen von Adrian V. S. Hill
Unternehmen | Position | Beginn |
---|---|---|
Oxxon Therapeutics, Inc.
Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oxxon Therapeutics, Inc. develops and manufactures antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The company has three development programs in hepatitis, melanoma, and HIV. Oxxon Therapeutics was founded in 1999 by Dr. Joerg Schneider and is located at Oxford, UK. | Gründer | - |
University of Oxford | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Adrian V. S. Hill
Unternehmen | Position | Ende |
---|---|---|
RioTech Pharmaceuticals Ltd.
RioTech Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology RioTech Pharmaceuticals Ltd. develops novel therapeutic drugs for hepatitis C virus. The company was founded on Nov 5, 2001 by Graham Foster, Adrian V. S. Hill, Peter Karayiannis, Howard David Thomas and Mark R. Thursz and is headquartered in Horsham, the United Kingdom. | Gründer | - |
Ausbildung von Adrian V. S. Hill
Magdalen College School Oxford Ltd | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Oxxon Therapeutics, Inc.
Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oxxon Therapeutics, Inc. develops and manufactures antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The company has three development programs in hepatitis, melanoma, and HIV. Oxxon Therapeutics was founded in 1999 by Dr. Joerg Schneider and is located at Oxford, UK. | Health Technology |
RioTech Pharmaceuticals Ltd.
RioTech Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology RioTech Pharmaceuticals Ltd. develops novel therapeutic drugs for hepatitis C virus. The company was founded on Nov 5, 2001 by Graham Foster, Adrian V. S. Hill, Peter Karayiannis, Howard David Thomas and Mark R. Thursz and is headquartered in Horsham, the United Kingdom. | Health Technology |